Uvadex

Uvadex (Methoxsalen) is a psoralen compound used in extracorporeal photopheresis therapy for immune system modulation. This treatment is typically administered under medical supervision for select skin and blood conditions. Suitable for patients undergoing specific photochemotherapy protocols.

Methoxsalen is primarily used as part of extracorporeal photopheresis, a procedure where the drug is combined with UVA light to treat certain immune-mediated skin conditions like cutaneous T-cell lymphoma. It may also be used for other autoimmune or inflammatory disorders as determined by a healthcare provider. Patients often ask, 'what is Methoxsalen used for' in the context of this specialized therapy.

Methoxsalen works by making the blood more sensitive to UVA light when exposed outside the body. This process helps modulate the immune response during treatment. Patients may notice temporary skin sensitivity or mild discomfort during or after the procedure. Effects vary based on individual treatment plans and medical conditions.

Methoxsalen should only be handled and administered by trained healthcare professionals in a controlled clinical setting. Protective measures, including eye protection and avoiding direct sunlight, are essential during and after treatment. Patients must follow medical guidance closely to minimize risks associated with photosensitivity.

Methoxsalen can interact with other drugs that increase photosensitivity, such as certain antibiotics or diuretics. Alcohol and tobacco may also affect treatment outcomes. Patients should inform their healthcare provider about all medications and supplements they are taking before starting Methoxsalen therapy.